藥物成份

共有 20983 個藥物成份

Bempedoic Acid

• 關聯藥證數量: 1

Benazepril HCl contains not less than 98.0% and not more than 102.0% of C24H28N2O5˙HCl calculated on the dried basis.

• 關聯藥證數量: 1

Benproperine Phosphate contains not less than 98.5% of C21H27NO.H3PO4 calculated on the dried basis.

• 關聯藥證數量: 1

Benserazide HCl contains not less than 98.5% and not more than 101.0% of C10H16ClN3O5, calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Benserazide Hydrochloride contains not less than 98.5% and not more than 101.0% of C10H16ClN3O5, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Benzarone contains not less than 99.0% and not more than 100.0% of C17H14O3, calculated on the dried basis.

• 關聯藥證數量: 1

Benzbromarone contains not less than 98.5% of C17H12Br2O3 calculated on the dried basis.

• 關聯藥證數量: 1

Benzethonium Chloride contains not less than 97.0% and not more than 103.0% of C27H42ClNO2, calcualted on the dried basis.

• 關聯藥證數量: 1

Benzocaine Definition Ethyl 4-aminobenzoate. Content: 99.0% to 101.0% (dried substance).

• 關聯藥證數量: 1

Benzocaine (standard grade) contains not less than 99.0 percent and not more than 101.0 percent of C9H11NO2, calculated on the dried substance.

• 關聯藥證數量: 1

Benzocaine contents 99.0% to 101.0% (dried substance)

• 關聯藥證數量: 1

Benzocaine, dried over phosphorus pentoxide for 3 hours, contains not less than 98.0 percent and not more than 102.0 percent of C9H11NO2.

• 關聯藥證數量: 1

Benzotriazole

• 關聯藥證數量: 1

Benzoyl Peroxide Hydrous contains not less than 90.0 % and not more than 110.0 % of C14H10O4. It contains a minimum of 20% of water.

• 關聯藥證數量: 1

Benzydamine Hydrochloride contains not less than 99.0% and not more than 101.0% of C19H23N3O, HCl, calculated with the dried substance.

• 關聯藥證數量: 1

Benzydamine Hydrochloride contains not less than 99.0% and not more than 101.0% of C19H23N3O,HCl, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Benzylpenicillin Procaine contains not less than 96.0% and not more than 102.0% of C13 H20N2O2,C6H18N2O4S, and not less than 39.0% and not more than 42.0% of C13H20N2O2, both calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Bepotastine Besilate 98.0%~102.0% (Anhydrous) (最終含量範圍)

• 關聯藥證數量: 1

Berberine Chloride contains not less than 95.0% and not more than 102.0% of C20H18ClNO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Berberine Hydrochloride contains not less than 95.0% and not more than 102.0% of C20H18ClNO4(mol. Wt.:371.841)，calculated on the anhydrous basis.

• 關聯藥證數量: 1

Berberine Sulfate 97-102%

• 關聯藥證數量: 1

Beta Carotene

• 關聯藥證數量: 1

Beta-2 Microglobulin Bead Pack (L2BM12)：beads coated with polyclonal goat anti-β2-microglobulin\nBeta-2 Microglobulin Reagent Wedge (L2BMA2)：alkaline phosphatase (bovine calf intestine) conjugated to murine monoclonal anti-β2-microglobulin in buffer.\nBeta-2 Microglobulin Adjustors (LBML, LBMH) \n (Low and High) of lyophilized β2-microglobulin in a synthetic matrix.

• 關聯藥證數量: 1

Betahistine Dihydrochloride (C8H12N2‧2HCl) contains 99.0 percent to 101.0 percent (dried substance).

• 關聯藥證數量: 1

Betahistine Dihydrochloride contains 99.0% ~ 101.0% of C8H14Cl2N2 (dried substance).

• 關聯藥證數量: 1

Betahistine Mesylate (e.q. Betahistine Dimesilate) contains not less than 98.0% and not more than 101.0% of C10H20N2O6S2, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Betamethasone (Betamethasone contains not less than 97.0 percent and not more than 103.0 percent of C22H29FO5, calculated on the dried basis.)

• 關聯藥證數量: 1

Betamethasone Dipropionate contains not less than 97.0% and not more than 103.0% of C28H37FO7, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone Dipropionate contains not less than 97.0% percent and not more than 103.0% percent of C28H37FO7, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone Dipropionate contents 97.0% to 102.0% (dried substance).

• 關聯藥證數量: 1

Betamethasone Sodium Phosphate contains not less than 96.0% and not more than 103.0% of C22H28FNa2O8P calculated on dried basis.

• 關聯藥證數量: 1

Betamethasone Sodium Phosphate contains not less than 96.0% and not more than 103.0% of C22H28FNa2O8P, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone Sodium Phosphate contains not less than 97.0 percent and not more than 103.0 percent of C22H28FNa2O8P, calcualted on the anhydrous basis.

• 關聯藥證數量: 1

Betamethasone Sodium Phosphate contains not less than 97.0 percent and not more than 103.0 percent of C22H28FNa2O8P, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Betamethasone Sodium Phosphate contents 96.0% to 103.0% (anhydrous substance).

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0 percent and not more than 103.0 percent of C27H37FO6, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on dried substance.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on the dried substance.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0%and not more than 103.0% of C27H37FO6,calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone contains 97.0% to 103.0% of C22H29FO5 (Dried substance)

• 關聯藥證數量: 1

Betamethasone contains not less than 97.0% and not more than 103.0% of C22H29FO5, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone contains not less than 97.0% and not more than the equivalent of 103.0% of C22H29FO5 calculated on the dried substance.

• 關聯藥證數量: 1

Betamethasone dipropionate contains not less than 97.0% and not more than the equivalent of 103.0% of 9-fluoro-11β-hydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Betamethasone sodium Phosphate content not less than 96.0% and not more than 103.0% of C22H28FNa2O8P, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Betamethasone sodium phosphate contains not less than 96.0% and not more than the equivalent of 103.0% of 9-fluoro-11β, 17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl disodium phosphate, calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Betamethasone valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on the dried substance.

• 關聯藥證數量: 1

Betamethasone valerate contains not less than 97.0% and not more than the equivalent of 103.0% of 9-fluoro-11b,21-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Betamethasone valerate contains not less than 97.0% and not more than the equivalent of 103.0% of C27H37FO6, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Betaxolol Hydrochloride contains not less than 98.5% and not more than 101.5% of C18H29NO3‧HCl, calculated on the dried substances.

• 關聯藥證數量: 1

Betaxolol Hydrochloride contains not less than 98.5% and not more than 101.5% of C18H30ClNO3 (dried substance).

• 關聯藥證數量: 1

Bethanechol Chloride contains not less than 98.0% and not more than 101.5% of C7H17ClN2O2, calculated on the anhydrous basis

• 關聯藥證數量: 1

Bethanechol Chloride contains not less than 98.0% and not more than 101.5% of bethanechol chloride (C7H17ClN2O2), calculated on the dried basis.

• 關聯藥證數量: 1

Bethanechol chloride contains not less than 98.0% and not more than 101.5% of C7H17ClN2O2, calculated on the dried basis.

• 關聯藥證數量: 1

Bezafibrate contains not less than 98.0% and not more than 102.0% of C19H20ClNO4 calculated on the dried basis.

• 關聯藥證數量: 1

Bezafibrate contains not less than 98.0% and not more than 102.0% of C19H20ClNO4, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Bezafibrate contains not less than 98.0% and not more than 102.0% of C19H20ClNO4,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Bictegravir Sodium

• 關聯藥證數量: 1

Bilastine (Form-I) contains not less than 98.0% and not more than 102.0% of C28H37N3O3, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bile Esculin Agar 43.5 g\n純水 1000 mL

• 關聯藥證數量: 1

Bilirubin : diazonium salt 3.1％Urobilinogen : diazonium salt 3.6％Ketones : sodium nitroprusside 2.0％Ascorbic acid : 2,6-dichlorophenolindophenol 0.7％Glucose : glucose oxidase 2.1％; peroxidase 0.9％; o-tolidine-hydroperoxidase 5.0％Protein : tetrabromophenol blue 0.2％Blood : tetramethylbenzidine-dihydrochloride 2.0％, isopropylbenzol- hydroperoxidase 21.0％pH : methyl red 2.0％; bromothymol blue 10.0％Nitrate : tetrahydrobenzo(h)quinoline-3-ol 1.5％; sulfanilic acid 1.9％Leukocytes : carboncylates 0.4％; diazonium salt 0.2％Specific Gravity : bromothymol blue 2.8％

• 關聯藥證數量: 1

Bilirubin is prepared from a bovine serumbase. Analyte levels are adjusted with bilirubin extracts and synthetic derivatives.

• 關聯藥證數量: 1

Bilirubin：0.4% w/w 2,4-dichloroaniline diazonium salt, balanced with buffer and non-reactive ingredients.Urobilinogen：2.9% w/w ρ-diethylaminobenzaldehyde balanced with buffer and nonreactive ingredients.

• 關聯藥證數量: 1

Bimatoprost contains not less than 98.0 percent and not more than 102.0 percent of C25H37NO4 calculated on the anhydrous and solvent free basis.

• 關聯藥證數量: 1

Binary lite reagent : polyclonal goat anti-cTnI antibody (0.15 ug/mL) labeled with acridinium ester, 2 monoclonal mouse anti-cTnI antibodies labeled with biotin (2.0 ug/mL),in buffer with protein stabilizers and preservatives Solid phase : latex magnetic particles in buffer with protein stabilizers and preservativesAncillary reagent : non-magnetic latex particles in buffer with sodium azide (＜0.1%)Calibrator : after reconstitution, low or high levels of synthetic human BNP in lyophilized buffered sodium caseinate with sodium azide (＜0.1%)

• 關聯藥證數量: 1

Binding Buffer Reagent(R1): a buffer (pH 8.7at 25 ℃) containing 12.8 μmol/L Ferrous Ammonium Sulfate, surfactants.\nColor Reagent(R2): a solution containg 240 mmol/L Ascorbic Acid, 6.1 mmol/L Ferene.

• 關聯藥證數量: 1

Binding Reagent (1): 10 x 1 ml: Ethanol, water\nWash Reagent (2): 10 x 3.2 ml: Cysteamine HCl, EDTA (ethylenediaminetetraacetic acid), KCl, MTG (monothioglycerol), PEG (polyethyleneglycol), Sodium azide 0.05% w/v, Tris, pH 7.0, Tween-20, Water\nElution Reagent (3): 10 x 2.0 ml: Ammonium sulfate, EDTA (ethylenediaminetetraacetic acid), Sodium azide 0.05% w/v, Tris, pH 7.0, Water\nLysis Reagent (4): 10 x 300μl: N-acetyl-L-cysteine, Guanidine thiocyanate, N-lauroylsarcosine, Sodium citrate, pH 6.8, Water

• 關聯藥證數量: 1

Binimetinib

• 關聯藥證數量: 1

Biosite Triage TOX Drug Screen Panel, APAP & THC： Contains murine monoclonal antibodies and drug metabolites labeled with a fluorescent dye or immobilized on the solid phase, and stabilizers.Triage TOX Drug Screen Controls： Human urine matrix containing parent compounds and/or major metabolites/analogues of drugs of abuse.

• 關聯藥證數量: 1

Biotinlyated Link, Streptavidin-Enyme, endogeneous Enzyme Block, Chromogen, Antibody Diluent

• 關聯藥證數量: 1

Biperiden Hydrochloride contains not less than 98.0% and not more than 101.0% of C21H29NO‧HCl, calculated on the dried substance.

• 關聯藥證數量: 1

Biperiden Hydrochloride contains not less than 99.0% and not more than 101.0% of C21H30ClNO, calculated on the dried substance.

• 關聯藥證數量: 1

Bis-Tris-Propane, pH 7.4 25 mmol/l NADH 0.18 mmol/l Pyruvate 1.2 mmol/l Preservative

• 關聯藥證數量: 1

Bis/Tris Buffer 100 mmol/L \nCreatine Phosphate 31.5 mmol/L\nAMP 5.3 mmol/L\nNADP 2.2 mmol/L\nEDTA 2.1 mmol/L\nP1P5-diAP 10.3μmol/L \nMg2+ 10.5 mmol/L\nADP 2.7 mmol/L\nD-Glucose 21 mmol/L\nN-acetyl-l-cysteine 21 mmol/L\nHexokinase (yeast) > 3000 U/L\nG-6-PDH (leuconostoc) > 2000 U/L\npH 6.80 at 20°C\n

• 關聯藥證數量: 1

Bisacodyl contains not less than 98.0% and not more than 101.0% of C22H19NO4, calculated on the dried basis.

• 關聯藥證數量: 1

Bisbentiamine contains not less than 98.0% and not more than 102.0% of C38H42N8O6S2.

• 關聯藥證數量: 1

Bismuth Subcarbonate contains not less than 97.6 percent and not more than 100.7 percent of (BiO)2CO3 Calculated On The Dried Basis.

• 關聯藥證數量: 1

Bismuth Subcarbonate contains not less than 97.6% and not more than 100.7% of (BiO)2CO3, calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subcarbonate contains not less than 97.6% and not more than 100.7% of (Bio)2CO3, calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subnitrate contains not less than 71.0% and not more than 74.0% of Bi, calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subnitrate contains not less than 79.0% of bismuth trioxide (Bi2O3), calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subnitrate is a salt that contains the equivalent of not less than 79.0% of bismuth trioxide (Bi2O3), calculated on the dried basis

• 關聯藥證數量: 1

Bismuth subcarbonate contains not less than 80% and not more than 82.5% of (BiO)2CO3, calculated with reference to the dried basis.

• 關聯藥證數量: 1

Bismuth subgallate contains not less than 48% and not more than 51% of Bi(Ar 209.0),calculated with reference to the dried basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate contains not less than 97.5% and not more than 102.0% of (C18H31NO4)2‧C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate contains not less than 97.5% of (C18H31NO4)2？C4H4O4 calculated on anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate contains the equivalent of not less than 831ug of Bisoprolol (C18H31NO4) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate cotnains not less than 97.5% and not more than 102.0% of (C18H91NO4)2˙C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol fumarate contains not less than 99.0 % and not more than 101.0 % of C40H66N2O12, calculated on anhydrous substance.

• 關聯藥證數量: 1

Biuret reagent\nSodium hydroxide 100 mmol/l\nNa-K-tartrate 16 mmol/l\nPotassium iodide 15 mmol/l\nCupric sulphate 6 mmol/l\nBlank reagent\nSodium hydroxide 100 mmol/l\nNa-K-tartrate 16 mmol/l\nStandard\nProtein 60 g/l (6.0 g/dl)

• 關聯藥證數量: 1

Bivalirudin contains not less than 95.0 percent and not more than 103.0 percent of C98H138N24O33 calculated on the anhydrous and trifluoroacetic acid free basis.

• 關聯藥證數量: 1

Blank.

• 關聯藥證數量: 1

Blend of polyviol alcohol 217, thymol and water

• 關聯藥證數量: 1

Bleomycin (sulfate)

• 關聯藥證數量: 1

Blood Clotting Accelerant-milk white spray, silicone dioxide 2.5% aqueous suspension 20 μl.\nSerum Separating Gel-light yellow, AP-TC polyolefine 0.6g (0.9g for ST740CG).

• 關聯藥證數量: 1

Blood Glucose Electrode:\nGlucose oxidase (Aspergillus niger)>=0.02 IU\nNon-reactive ingredients >=60ug

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-D (Anti-Rho) is a low- protein reagent prepared from human monoclonal IgM anti-D and human serum containing IgG anti-D.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-Fya is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique. The final formulation includes bovine albumin in a sodium chloride solution at a final total protein concentration within the range from 5 to 18%.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-Fyb is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique. The final formulation includes bovine albumin in a sodium chloride solution at a final total protein concentration within the range from 5 to 18%.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-JKa (clone MS15) is prepared from human/mouse heterohybridoma cell line secreting human IgM antibody and is designed for recognition of its corresponding antigen on human red blood cells.

• 關聯藥證數量: 1